The global fatty liver disease Sustainable Development Goal country score for 195 countries and territories

Author:

Lazarus Jeffrey V.1234ORCID,Han Hannah5,Mark Henry E.2ORCID,Alqahtani Saleh A.6,Schattenberg Jörn M.7ORCID,Soriano Joan B.89,White Trenton M.1ORCID,Zelber-Sagi Shira1011ORCID,Dirac M. Ashworth512,

Affiliation:

1. Barcelona Institute for Global Health (ISGlobal), Hospital Clínic, University of Barcelona, Barcelona, Spain

2. EASL International Liver Foundation, Geneva, Switzerland

3. Faculty of Medicine and Health Sciences, University of Barcelona, Barcelona, Spain

4. CUNY Graduate School of Public Health and Health Policy (CUNY SPH), New York, New York, USA

5. Institute for Health Metrics and Evaluation, University of Washington, Seattle, Washington, USA

6. Organ Transplant Center, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia

7. I. Department of Medicine, Metabolic Liver Research Program, University Medical Center, Mainz, Germany

8. Respiratory Department, Hospital Universitario de la Princesa; School of Medicine, Universidad Autónoma de Madrid, Madrid, Spain

9. Centro de Investigación en Red de Enfermedades Respiratorias (CIBERES), Instituto de Salud Carlos III (ISCIII), Madrid, Spain

10. School of Public Health, University of Haifa, Haifa, Israel

11. Department of Gastroenterology, Tel Aviv Medical Center, Tel Aviv, Israel

12. Department of Health Metrics Sciences, Department of Family Medicine, University of Washington, Seattle, Washington, USA

Abstract

Background and Aims: Fatty liver disease is highly prevalent, resulting in overarching wellbeing and economic costs. Addressing it requires comprehensive and coordinated multisectoral action. We developed a fatty liver disease Sustainable Development Goal (SDG) country score to provide insights into country-level preparedness to address fatty liver disease through a whole-of-society lens. Approach and Results: We developed 2 fatty liver disease–SDG score sets. The first included 6 indicators (child wasting, child overweight, noncommunicable disease mortality, a universal health coverage service coverage index, health worker density, and education attainment), covering 195 countries and territories between 1990 and 2017. The second included the aforementioned indicators plus an urban green space indicator, covering 60 countries and territories for which 2017 data were available. To develop the fatty liver disease–SDG score, indicators were categorized as “positive” or “negative” and scaled from 0 to 100. Higher scores indicate better preparedness levels. Fatty liver disease–SDG scores varied between countries and territories (n = 195), from 14.6 (95% uncertainty interval: 8.9 to 19.4) in Niger to 93.5 (91.6 to 95.3) in Japan; 18 countries and territories scored > 85. Regionally, the high-income super-region had the highest score at 88.8 (87.3 to 90.1) in 2017, whereas south Asia had the lowest score at 44.1 (42.4 to 45.8). Between 1990 and 2017, the fatty liver disease–SDG score increased in all super-regions, with the greatest increase in south Asia, but decreased in 8 countries and territories. Conclusions: The fatty liver disease–SDG score provides a strategic advocacy tool at the national and global levels for the liver health field and noncommunicable disease advocates, highlighting the multisectoral collaborations needed to address fatty liver disease, and noncommunicable diseases overall.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Hepatology

Reference46 articles.

1. Knowing what’s out there: awareness of non-alcoholic fatty liver disease;Ghevariya;Front Med (Lausanne),2014

2. The global NAFLD policy review and preparedness index: Are countries ready to address this silent public health challenge?;Lazarus;J Hepatol,2022

3. The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis;Riazi;Lancet Gastroenterol Hepatol,2022

4. Fatty liver disease in an autopsy series of children and adolescents;Yüksel;Hippokratia,2012

5. Prevalence of fatty liver in children and adolescents;Schwimmer;Pediatrics,2006

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3